Akoustis Technologies, Inc. General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

3 Months Ended

12 Months Ended

Sep. 30, 2017

Jun. 30, 2017

Equity [Abstract]

Schedule of stock-based compensation expense

The fair values of the Company’s options were estimated at the dates of grant using a Black-Scholes option pricing model with the following weighted average assumptions:

Expected term (years)	6.25
Risk-free interest rate	1.72	%
Volatility	88	%
Dividend yield	0	%

he Company recorded stock-based compensation expense for the shares issued to consultants that have vested, which is a component of operating expenses in the Consolidated Statement of Operations as follows:

			Stock-Based Compensation

			For the Year Ended
Month of Original Grant	Shares Issued		June 30, 2017		June 30, 2016
December 2015		230,000	$	945,189	$	342,811
March 2016		60,000		261,214		71,786
August 2016		40,000		147,600		—
January 2017		50,000		194,776		—
		380,000	$	1,548,779	$	414,597

Schedule of Black-Scholes option pricing model with weighted average assumptions

The fair values of the Company’s options were estimated at the dates of grant using a Black-Scholes option pricing model with the following weighted average assumptions:

Expected term (years)	6.25
Risk-free interest rate	1.29	%
Volatility	47	%
Dividend yield	0	%

Schedule of option activity

The following is a summary of the option activity:

	Options		Weighted Average Exercise Price
Outstanding - June 30, 2017		160,000	$	1.50
Exercisable - June 30, 2017		80,000	$	1.50
Granted		515,000		7.12
Exercised		—		—
Forfeited/Cancelled		—		—
Outstanding - September 30, 2017		675,000	$	5.79
Exercisable - September 30, 2017		80,000	$	1.50

The following is a summary of the option activity:

	Options		Weighted Average Exercise Price
Outstanding – July 1, 2015		160,000	$	1.50
Exercisable – July 1, 2015		—	$	—
Granted		—		—
Exercised		—		—
Forfeited/Cancelled		—		—
Outstanding – June 30, 2016		160,000		1.50
Exercisable – June 30, 2016		40,000		1.50
Granted		—		—
Exercised		—		—
Forfeited/Cancelled		—		—
Outstanding – June 30, 2017		160,000	$	1.50
Exercisable – June 30, 2017		80,000	$	1.50

Schedule of resricted shares

The following is a summary of restricted shares:

Grant Date	Shares Issued		Fair Value (1)		Shares Vested
June 2014		307,876	$	389,568		121,530
July 2014		32,408		48,612		36,956
August 2014		81,020		153,348		24,306
September 2014		129,633		180,874		15,185
March 2015		72,918		243,713		—
October 2015		293,000		411,000		—
November 2015		36,200		42,150		—
December 2015		300,000		105,000		230,000
January 2016		40,000		68,000		—
March 2016		60,000		—		60,000
June 2016		118,000		512,990		—
August 2016		351,000		1,179,274		40,000
January 2017		192,000		973,675		50,000
February 2017		110,000		697,500		—
March 2017		20,000		—		—
July 2017		100,000		745,000		—
		2,244,055	$	5,750,704		577,977

(1)	The fair value of the restricted stock awards as shown above is based on either the balance sheet date for consultants or grant date for employees.

The following is a summary of restricted shares:

Grant Date	Shares Issued		Fair Value (1)		Shares Vested
June 2014		307,876	$	1,294,029		121,530
July 2014		32,408		48,612		23,791
August 2014		81,020		326,323		8,102
September 2014		129,633		352,282		13,667
March 2015		72,918		401,717		—
October 2015		293,000		439,500		—
November 2015		36,200		54,300		—
December 2015		300,000		1,393,000		230,000
January 2016		40,000		68,000		—
March 2016		60,000		333,000		60,000
June 2016		118,000		535,809		—
August 2016		351,000		1,489,247		40,000
January 2017		192,000		1,165,122		—
February 2017		110,000		697,500		—
March 2017		20,000		135,000		—
		2,144,055	$	8,733,441		497,090